181 related articles for article (PubMed ID: 36426920)
21. Metformin suppresses lung adenocarcinoma by downregulating long non-coding RNA (lncRNA) AFAP1-AS1 and secreted phosphoprotein 1 (SPP1) while upregulating miR-3163.
Qiu C; Li C; Zheng Q; Fang S; Xu J; Wang H; Guo H
Bioengineered; 2022 May; 13(5):11987-12002. PubMed ID: 35603556
[TBL] [Abstract][Full Text] [Related]
22. Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.
Mao G; Mu Z; Wu DA
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1484-1494. PubMed ID: 34605863
[TBL] [Abstract][Full Text] [Related]
23. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
[TBL] [Abstract][Full Text] [Related]
24. Expression profile analysis of LncRNAs and mRNAs in pre-receptive endometrium of women with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer.
Xu X; Yang A; Tian P; Zhang K; Liu Y; Wang Y; Wang Z; Wu Y; Zhao Z; Li Q; Shi B; Huang X; Hao GM
BMC Med Genomics; 2024 Jan; 17(1):26. PubMed ID: 38243290
[TBL] [Abstract][Full Text] [Related]
25. Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis.
He F; Huang L; Xu Q; Xiong W; Liu S; Yang H; Lu W; Xiao R; Hu Z; Cai L
Cancer Med; 2020 Oct; 9(20):7717-7728. PubMed ID: 32869486
[TBL] [Abstract][Full Text] [Related]
26. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
Hou J; Yao C
Biomed Res Int; 2021; 2021():8859996. PubMed ID: 33511215
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA ZFPM2-AS1 is involved in lung adenocarcinoma via miR-511-3p/AFF4 pathway.
Li J; Ge J; Yang Y; Liu B; Zheng M; Shi R
J Cell Biochem; 2020 Mar; 121(3):2534-2542. PubMed ID: 31692047
[TBL] [Abstract][Full Text] [Related]
28. Preliminary screening and correlation analysis for lncRNAs related to radiosensitivity in melanoma cells by inhibiting glycolysis.
Wang Q; Huang C; Hu Y; Yan W; Gong L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):565-574. PubMed ID: 34275924
[TBL] [Abstract][Full Text] [Related]
29. A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression.
Chen S; Yu Y; Yuan Y; Chen X; Zhou F; Li Y; Wang P; Jiang X; Tian S; Ren W
Aging (Albany NY); 2022 Dec; 14(24):9924-9941. PubMed ID: 36490353
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
[TBL] [Abstract][Full Text] [Related]
31. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
32. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
Zheng J; Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Li Z; Ming L; Qin Z
J Clin Lab Anal; 2021 Nov; 35(11):e23951. PubMed ID: 34558724
[TBL] [Abstract][Full Text] [Related]
33. LncRNA SBF2-AS1 inhibits apoptosis and promotes proliferation in lung cancer cell via regulating FOXM1.
Qi H; Wang L; Zhang X; Sun W; Liu J
J BUON; 2020; 25(4):1761-1770. PubMed ID: 33099911
[TBL] [Abstract][Full Text] [Related]
34. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
36. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
37. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
39. Identification of Circulating lncRNA Expression Profiles in Patients with Atrial Fibrillation.
Ruan ZB; Wang F; Gongben BD; Chen GC; Zhu L
Dis Markers; 2020; 2020():8872142. PubMed ID: 33299500
[TBL] [Abstract][Full Text] [Related]
40. ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to the malignant phenotype of lung adenocarcinoma cells via miR-3681-3p/NEK2 axis.
Wang B; Cai Y; Li X; Kong Y; Fu H; Zhou J
Cell Cycle; 2021 Dec; 20(24):2607-2618. PubMed ID: 34850664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
